Tag Archives: BACR

Barbara Conway’s research explored the reasons why people from deprived socio-economic backgrounds access phase 3 cardiac rehabilitation services less than others. She calls these patients the ‘unheard’ in the health service. The study gathered interview data from 10 inhabitants of the five poorest electoral wards in Darlington, aiming to discover common beliefs about the health services which might cause the discrepancy. Some of the findings looked at inhibitors to cardiac rehabilitation with participants saying that they could not see the perceived benefit of cardiac rehabilitation in achieving lifestyle goals. Instead they focused on

The registry study, published in Journal of the American Medical Association (January 12th, 2011 issue), involved 30,254 patients, of whom 2,500 were taking losartan and 2,639 were taking candesartan. One-year survival was 90% for patients receiving candesartan and 83% for those taking losartan. Five-year survival was 61% and 44%, respectively. In multivariate analysis with adjustment for propensity scores, the hazard ratio for mortality for losartan compared with candesartan was 1.43 (p<0.001). The authors, led by Dr Maria Eklind-Cervenka (South Hospital, Stockholm, Sweden) note that the difference remained significant even after adjustme